Search
forResearch 10 of 538
- Localization of Plasminogen Activator Inhibitor Type 2 (PAI-2) in Hair and Nail: Implications for Terminal Differentiation
- Laboratory and clinical haemostatic aberrations in primary dermatologic disease: A review
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Genetic basis of polycystic ovary syndrome
- Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries
- Minoxidil Regulates Aging-Like Phenotypes in Rat Cortical Astrocytes <i>In Vitro</i>
- Long‐read sequencing reveals SVA insertion in <i>AP3B1</i> causing Hermansky–Pudlak syndrome 2
- Deletion of adipocyte Sine Oculis Homeobox Homolog 1 prevents lipolysis and attenuates skin fibrosis
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →